company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,115779000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,221894000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,77682000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,83778000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,22775000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,521908000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,212620000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,118085000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,40360000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,77985000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14558000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,250988000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,,totalassets,Total Assets,=,debit,usd,985516000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,83930000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,83930000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,497083000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,41541000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,538624000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,622554000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,931463000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-576410000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,10224000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-2315000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,362962000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,362962000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,362962000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q2,,2010-06-30,2010-08-04 16:33:00+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,985516000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,127539000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,224428000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,78734000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,91741000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,31747000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,554189000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,213755000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,90116000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,53364000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,104604000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,228505000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,476589000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,,totalassets,Total Assets,=,debit,usd,1244533000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,92097000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcurrentliabilities,currentdeferredrevenue,Current Deferred Revenue,+,credit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,92097000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,497083000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,69689000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,566772000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,658869000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,948497000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-359076000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1581000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-2176000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,585664000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,585664000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,585664000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2010.0,Q3,,2010-09-30,2010-10-29 12:46:13+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1244533000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,90782000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,161799000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,106198000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,110067000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,34984000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,503830000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,217884000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,142511000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,53055000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,102692000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,231947000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,12227000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,542432000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,,totalassets,Total Assets,=,debit,usd,1264146000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,75986000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,75986000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,377521000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,89799000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,467320000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,543306000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1103996000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-375636000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5787000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-1733000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,720840000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,720840000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,720840000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q1,,2011-03-31,2011-04-29 13:08:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1264146000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,112956000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,145964000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,106606000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,112299000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,36286000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,514111000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,216496000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,154327000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,53055000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,101736000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,228400000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,12267000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,549785000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,,totalassets,Total Assets,=,debit,usd,1280392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,82035000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,82035000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,377520000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,88532000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,466052000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,548087000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1122844000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-380713000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-5923000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-3903000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,732305000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,732305000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,732305000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q2,,2011-06-30,2011-08-01 14:20:14+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1280392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,71254000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,153120000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,107057000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,115628000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,39965000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,487024000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,266190000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,146808000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,51543000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,100780000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,229172000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,13559000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,541862000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,,totalassets,Total Assets,=,debit,usd,1295076000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,83254000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,83254000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,348339000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,88944000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,437283000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,520537000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1175536000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-398366000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1304000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-3935000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,774539000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,774539000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,774539000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2011.0,Q3,,2011-09-30,2011-10-31 14:26:11+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1295076000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,82586000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,150393000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,105828000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,124064000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,50519000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,513390000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,264317000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,55833000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,51543000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,170914000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,221239000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,19849000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,519378000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,,totalassets,Total Assets,=,debit,usd,1297085000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,23455000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,96359000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,119814000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,324872000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,80449000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,405321000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,525135000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1222049000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-449073000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2512000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-3538000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,771950000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,771950000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,771950000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q1,,2012-03-31,2012-04-30 17:13:48+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1297085000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,177757000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,224829000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,100750000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,120125000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,58073000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,681534000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,267374000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,123155000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,51543000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,168267000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,220593000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,20061000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,583619000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,,totalassets,Total Assets,=,debit,usd,1532527000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,23440000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,96557000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,119997000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,324865000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,87239000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,412104000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,532101000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1483459000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-481079000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4650000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-6604000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1000426000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1000426000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1000426000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q2,,2012-06-30,2012-08-02 15:30:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1532527000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,181330000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,245125000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,117290000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,120825000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,54816000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,719386000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,273724000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,107589000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,51543000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,165624000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,229771000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,19739000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,574266000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,,totalassets,Total Assets,=,debit,usd,1567376000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,23440000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,111489000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,134929000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,324861000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,92392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,417253000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,552182000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1505900000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-486436000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2333000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-6603000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1015194000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1015194000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1015194000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2012.0,Q3,,2012-09-30,2012-10-29 17:01:24+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1567376000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,154380000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,247502000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,120345000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,135822000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,29474000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,35501000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,723024000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,281865000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,124498000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,54975000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,172016000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,226757000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,15158000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,593404000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,,totalassets,Total Assets,=,debit,usd,1598293000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,144008000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,144008000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,109849000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,37521000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,56763000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,204133000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,348141000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1833970000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-579258000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,1155000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-5715000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1250152000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1250152000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1250152000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q1,,2013-03-31,2013-04-29 15:07:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1598293000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,175445000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,225116000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,115063000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,142296000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,29474000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,33526000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,720920000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,282002000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,124906000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,54975000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,168434000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,235400000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14883000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,598598000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,,totalassets,Total Assets,=,debit,usd,1601520000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,142241000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,142241000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,109822000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,37182000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,54017000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,201021000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,343262000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1864101000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-600791000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2441000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-7493000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1258258000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1258258000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1258258000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q2,,2013-06-30,2013-07-29 14:01:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1601520000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,181565000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,198086000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,124745000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,148684000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,32238000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,28161000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,713479000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,285664000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,148625000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,54258000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,165791000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,238703000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,14010000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,621387000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,,totalassets,Total Assets,=,debit,usd,1620530000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,167633000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,167633000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,78310000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,37190000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,60911000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,176411000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,344044000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,1926275000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-653811000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,11473000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-7451000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1276486000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1276486000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1276486000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2013.0,Q3,,2013-09-30,2013-10-28 13:17:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,1620530000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,639778000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,247703000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,110462000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,176893000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,30561000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,41013000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1246410000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,437066000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,251928000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,54258000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,165397000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,144124000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,41545000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,657252000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,,totalassets,Total Assets,=,debit,usd,2340728000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,156038000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,156038000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,661419000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,63150000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,724569000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,880607000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2213493000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-753916000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,7275000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-6731000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1460121000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1460121000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1460121000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q1,,2014-03-31,2014-05-02 12:15:41+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2340728000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,584717000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,251901000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,122282000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,193498000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,30561000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,37268000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1220227000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,469862000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,244588000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,54258000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,163045000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,147143000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,46562000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,655596000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,,totalassets,Total Assets,=,debit,usd,2345685000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,166720000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,166720000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,650872000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,66124000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,716996000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,883716000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2249592000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-787418000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,9941000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-10146000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1461969000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1461969000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1461969000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q2,,2014-06-30,2014-07-31 13:33:51+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2345685000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,398005000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,268368000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,121395000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,204444000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,29149000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,56458000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1077819000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,486741000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,449143000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,54258000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,159949000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,150991000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,61532000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,875873000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,,totalassets,Total Assets,=,debit,usd,2440433000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,206550000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,206550000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,656884000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,68557000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,725441000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,931991000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,2278909000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-779973000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,19189000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-9683000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1508442000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1508442000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1508442000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2014.0,Q3,,2014-09-30,2014-10-28 15:09:33+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,2440433000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,900570000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,108119000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,175738000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,222833000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,31203000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,84265000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1522728000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,538117000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,224810000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,202392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,926896000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,163411000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,80332000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1597841000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,,totalassets,Total Assets,=,debit,usd,3658686000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,75294000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,230212000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,305506000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,655491000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,193202000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,79032000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,927725000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1233231000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3308298000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-917271000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,43819000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-9391000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2425455000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2425455000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2425455000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q1,,2015-03-31,2015-05-05 11:35:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3658686000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,440664000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,240889000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,186083000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,237532000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,31203000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,77558000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1213929000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,568051000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,509627000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,202392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,923861000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,172545000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,58284000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1866709000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,,totalassets,Total Assets,=,debit,usd,3648689000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,91374000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,256330000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,347704000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,661492000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,193202000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,89334000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,944028000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1291732000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3337664000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-999260000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,32461000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-13908000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2356957000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2356957000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2356957000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q2,,2015-06-30,2015-08-05 06:04:42+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3648689000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,376346000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,241984000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,148949000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,262100000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcurrentassets,currentdeferredtaxassets,Current Deferred & Refundable Income Taxes,+,debit,usd,30880000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,115330000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1175589000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,604513000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,514381000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,202392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,920943000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,146245000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,60790000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1844751000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,,totalassets,Total Assets,=,debit,usd,3624853000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,94291000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,296200000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,390491000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,667793000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,193202000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,80727000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,941722000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1332213000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3371539000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1090186000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,25184000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-13897000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2292640000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2292640000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2292640000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2015.0,Q3,,2015-09-30,2015-11-02 09:36:06+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3624853000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,270453000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,186400000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,180751000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,296979000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,58207000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,992790000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,716916000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,314404000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,1177232000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,243212000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,25400000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1957287000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,,totalassets,Total Assets,=,debit,usd,3666993000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,97449000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,290562000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,388011000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,668009000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,143527000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,177210000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,988746000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1376757000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3410460000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1106711000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,47000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-13560000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2290236000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2290236000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2290236000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q1,,2016-03-31,2016-05-02 09:01:57+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3666993000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,305969000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,197318000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,214158000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,326556000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,61945000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1105946000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,724494000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,201620000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,568966000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,266182000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,23057000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1256864000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,,totalassets,Total Assets,=,debit,usd,3087304000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,72238000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,292342000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,364580000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,645685000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,159463000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,805148000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1169728000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,3458288000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1530271000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,4528000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-14969000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,1917576000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,1917576000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,1917576000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q2,,2016-06-30,2016-08-08 09:30:39+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3087304000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,707349000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,327499000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,215894000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,347420000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,68409000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1666571000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,729836000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,362956000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,561387000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,288006000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,36443000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1445831000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,,totalassets,Total Assets,=,debit,usd,3842238000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,71206000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,306129000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,377335000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,653178000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalnoncurrentliabilities,noncurrentdeferredtaxliabilities,Noncurrent Deferred & Payable Income Tax Liabilities,+,credit,usd,0.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,165917000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,819095000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1196430000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4231687000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1573068000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,2158000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-14969000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2645808000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2645808000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2645808000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2016.0,Q3,,2016-09-30,2016-11-03 09:01:59+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3842238000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,348234000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,329821000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,230250000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,384143000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,60340000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1352788000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,824013000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,533628000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,546172000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,458387000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,26580000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1761806000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,,totalassets,Total Assets,=,debit,usd,3938607000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,67759000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,272447000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,340206000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,668437000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,160877000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,829314000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1169520000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4314966000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1536796000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,5020000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-14103000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2769087000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2769087000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2769087000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q1,,2017-03-31,2017-05-04 16:42:07+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,3938607000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,354864000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,372912000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,238338000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,429831000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,62875000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1458820000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,851097000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,482036000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,538565000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,470961000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,21447000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1710048000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,,totalassets,Total Assets,=,debit,usd,4019965000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,55093000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,319210000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,374303000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,676205000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,173878000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,850083000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1224386000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4398155000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1573629000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-14658000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-14289000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2795579000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2795579000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2795579000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q2,,2017-06-30,2017-08-02 17:31:36+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4019965000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,431399000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,825700000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,251891000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,457393000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,83646000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2050029000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,878624000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,416304000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,530957000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,484759000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,22985000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1652044000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,,totalassets,Total Assets,=,debit,usd,4580697000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,52609000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,364920000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,417529000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,1166036000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,183570000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1349606000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1767135000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4435625000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1586156000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-21434000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-14473000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2813562000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2813562000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2813562000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2017.0,Q3,,2017-09-30,2017-10-31 16:13:29+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4580697000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,473980000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,908815000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,318394000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,468161000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,71760000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2241110000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,895392000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,313599000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,509902000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,407009000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,32666000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1460215000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,,totalassets,Total Assets,=,debit,usd,4596717000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,426933000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,346538000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,773471000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,817672000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,198571000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,1016243000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1789714000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4510628000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1661063000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-28545000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-14017000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2807003000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2807003000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2807003000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q1,,2018-03-31,2018-04-27 06:06:22+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4596717000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,427411000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,935662000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,363566000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,473356000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,80072000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2280067000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,900480000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,279988000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,502295000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,425380000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,39430000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1444132000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,,totalassets,Total Assets,=,debit,usd,4624679000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,446218000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,358732000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,804950000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,821871000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,112754000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,934625000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1739575000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4577478000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1677855000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-1129000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-13390000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2885104000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2885104000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2885104000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q2,,2018-06-30,2018-08-03 06:06:15+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4624679000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,882184000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,561192000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,384343000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,508482000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,71652000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,2407853000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,924033000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,204883000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,494687000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,429194000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,37565000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1363368000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,,totalassets,Total Assets,=,debit,usd,4695254000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,460434000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,378226000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,838660000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,826119000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,115530000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,941649000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1780309000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4620995000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1690475000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,-2160000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-13415000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2914945000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2914945000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2914945000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2018.0,Q3,,2018-09-30,2018-10-26 06:06:50+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4695254000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,364369000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,530485000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,393429000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,534696000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,93876000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1916855000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,951890000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,320000000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,485981000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,467333000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,96300000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1566653000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,,totalassets,Total Assets,=,debit,usd,4435398000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,88156000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,412830000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,500986000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,834766000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,163019000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,997785000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1498771000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4683079000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1753334000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,19794000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-12912000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2936627000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2936627000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2936627000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q1,,2019-03-31,2019-04-29 06:08:45+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4435398000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,307577000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,423526000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,377150000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,578736000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,119779000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1806768000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,962970000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,374965000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,476632000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,475554000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,99456000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1623646000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,,totalassets,Total Assets,=,debit,usd,4393384000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,9926000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,429502000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,439428000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,839165000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,153837000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,993002000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1432430000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4744495000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1790769000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,17439000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-10211000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,2960954000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,2960954000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,2960954000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q2,,2019-06-30,2019-08-02 06:10:18+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4393384000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcurrentassets,cashandequivalents,Cash & Equivalents,+,debit,usd,423220000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcurrentassets,shortterminvestments,Short-Term Investments,+,debit,usd,297572000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcurrentassets,accountsreceivable,Accounts Receivable,+,debit,usd,402970000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcurrentassets,netinventory,"Inventories, net",+,debit,usd,609049000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcurrentassets,othercurrentassets,Other Current Assets,+,debit,usd,126548000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalassets,totalcurrentassets,Total Current Assets,+,debit,usd,1859359000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalassets,netppe,"Plant, Property, & Equipment, net",+,debit,usd,969300000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalnoncurrentassets,longterminvestments,Long-Term Investments,+,debit,usd,431804000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalnoncurrentassets,goodwill,Goodwill,+,debit,usd,197039000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalnoncurrentassets,intangibleassets,Intangible Assets,+,debit,usd,462849000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalnoncurrentassets,noncurrentdeferredtaxassets,Noncurrent Deferred & Refundable Income Taxes,+,debit,usd,525131000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalnoncurrentassets,othernoncurrentassets,Other Noncurrent Operating Assets,+,debit,usd,112646000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalassets,totalnoncurrentassets,Total Noncurrent Assets,+,debit,usd,1729469000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,,totalassets,Total Assets,=,debit,usd,4558128000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcurrentliabilities,shorttermdebt,Short-Term Debt,+,credit,usd,10000000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcurrentliabilities,accountspayable,Accounts Payable,+,credit,usd,483745000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalliabilities,totalcurrentliabilities,Total Current Liabilities,+,credit,usd,493745000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalnoncurrentliabilities,longtermdebt,Long-Term Debt,+,credit,usd,843616000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalnoncurrentliabilities,othernoncurrentliabilities,Other Noncurrent Operating Liabilities,+,credit,usd,146362000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalliabilities,totalnoncurrentliabilities,Total Noncurrent Liabilities,+,credit,usd,989978000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalliabilitiesandequity,totalliabilities,Total Liabilities,+,credit,usd,1483723000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcommonequity,commonequity,Common Stock,+,credit,usd,4783096000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcommonequity,retainedearnings,Retained Earnings,+,credit,usd,-1735733000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcommonequity,aoci,Accumulated Other Comprehensive Income / (Loss),+,credit,usd,37003000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalcommonequity,otherequity,Other Equity Adjustments,+,credit,usd,-9961000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalequity,totalcommonequity,Total Common Equity,+,credit,usd,3074405000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalequityandnoncontrollinginterests,totalequity,Total Preferred & Common Equity,+,credit,usd,3074405000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,totalliabilitiesandequity,totalequityandnoncontrollinginterests,Total Equity & Noncontrolling Interests,+,credit,usd,3074405000.0
Biomarin Pharmaceutical Inc,BMRN,NSLL8ITTRR0J5HEMR848,0001048477,2019.0,Q3,,2019-09-30,2019-11-04 07:36:19+00:00,,totalliabilitiesandequity,Total Liabilities & Shareholders' Equity,=,credit,usd,4558128000.0
